Administering the PPV to all adult populations will decrease rates of pneumococcal pneumonia, however, does not
decrease all-cause mortality, so it should be administered in populations where invasive pneumococcal disease is a risk.
This document was created by a medical student enrolled in the Primary Care Clerkship at the
University of Minnesota Medical School as part of the course project. The aim of the project is
to present information on a medical topic in the format of a patient education handout. It does
not necessarily reflect the views of the University of Minnesota Medical School physicians and
faculty. These materials are provided for informational purposes only and are in no way intended
to take the place of the advice and recommendations of your personal health care provider. The
information provided may no longer be up to date since it has not been reviewed since the date of
creation. The information provided should not be used to diagnose a health problem or disease, or
as a means of determining treatment. In the event of a medical emergency, immediately contact a
doctor or call 911.